Scinai Immunotherapeutics Investor Relations Material
Latest events
Status Update
Scinai Immunotherapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Scinai Immunotherapeutics Ltd
Access all reports
Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is an Israeli biopharmaceutical company primarily engaged in the development, manufacture, and commercialization of innovative biological products. The company's focus is on inflammation and immunology, with a particular emphasis on autoimmune and infectious diseases. Scinai's product development pipeline includes a range of nanosized antibodies, known as NanoAbs, derived from alpacas. These antibodies target various diseases with significant unmet medical needs. Additionally, Scinai operates a boutique contract development and manufacturing organization (CDMO) that provides comprehensive services to pharmaceutical, biotech, and alternative protein food tech companies. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SCNI
Country
🇺🇸 United States